Abstract
TO EVALUATE THE DRUG UTILIZATION PATTERN AND PHARMACOECONOMICS ON ACUTE CORONARY SYNDROME IN A TERTIARY CARE HOSPITAL

Nayana P. Kunderi, Mohammed Ismail C.*, Jeena Susan Saji, Arbind Sah, Sabrina K. S., Dr. E. Satheesh Kumar, Dr. Yashaswini P. and Dr. Narayana Swamy V. B.

ABSTRACT

Cross sectional study was carried out among 200 inpatients in a tertiary care hospital Bangalore. Patients diagnosed with ACS from the cardiology department were included in the study. Out of 200 patients with ACS, majority were males (136) and females were (64). The common co-morbidities related to ACS were Diabetes, Hypertension, Dyslipidemia and the majority of the patients were diagnosed with Anterior Wall MI followed by Unstable angina. The most frequently prescribed drugs were (Antiplatelet 45.8%) followed by Antihyperlipidemic (21.7%) followed by Antianginal (17.01%) and Antihypertensive (15.4%). The average number of drugs per prescription was (6.94%). Drugs prescribed by generic name was (4.62%). Antibiotic constituted only (17%) of the total number of encounters. The frequency of the use of the injectable preparation was (52%). The percentage of drug from the essential drug list was (100%). Polypharmacy was observed in our study. The current research provides valuable insights into overall pattern of drugs used in acute coronary syndrome The study encouraged physicians to prescribe more generic drugs to reduce avoidable cost burdens to patients as well as to decrease polypharmacy especially in geriatric patients.

Keywords: ACUTE CORONARY SYNDROME, DRUG UTILIZATION EVALUATION, PHARMACOECONOMICS.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2022 Issue has been successfully launched on 1 NOVEMBER 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT